Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8DCH

Crystal Structure of a highly resistant HIV-1 protease Clinical isolate PR10x with GRL-0519 (tris-tetrahydrofuran as P2 ligand)

8DCH の概要
エントリーDOI10.2210/pdb8dch/pdb
関連するPDBエントリー3PWM 3PWR 6DIL 6DJ2 6DJ5 8DCI
分子名称Protease, (3R,3aS,3bR,6aS,7aS)-octahydrodifuro[2,3-b:3',2'-d]furan-3-yl [(1S,2R)-1-benzyl-2-hydroxy-3-{[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino}propyl]carbamate, CHLORIDE ION, ... (5 entities in total)
機能のキーワードhiv/aids, hiv protease, drug resistant clinical mutant, evolution of drug resistance, distal mutations, viral protein, hydrolase-inhibitor complex, hydrolase/inhibitor
由来する生物種Human immunodeficiency virus 1
タンパク質・核酸の鎖数2
化学式量合計22336.83
構造登録者
Wong-Sam, A.E.,Wang, Y.-F.,Weber, I.T. (登録日: 2022-06-16, 公開日: 2022-10-05, 最終更新日: 2023-10-18)
主引用文献Wong-Sam, A.,Wang, Y.F.,Kneller, D.W.,Kovalevsky, A.Y.,Ghosh, A.K.,Harrison, R.W.,Weber, I.T.
HIV-1 protease with 10 lopinavir and darunavir resistance mutations exhibits altered inhibition, structural rearrangements and extreme dynamics.
J.Mol.Graph.Model., 117:108315-108315, 2022
Cited by
PubMed Abstract: Antiretroviral drug resistance is a therapeutic obstacle for people with HIV. HIV protease inhibitors darunavir and lopinavir are recommended for resistant infections. We characterized a protease mutant (PR10x) derived from a highly resistant clinical isolate including 10 mutations associated with resistance to lopinavir and darunavir. Compared to the wild-type protease, PR10x exhibits ∼3-fold decrease in catalytic efficiency and K values of 2-3 orders of magnitude worse for darunavir, lopinavir, and potent investigational inhibitor GRL-519. Crystal structures of the mutant were solved in a ligand-free form and in complex with GRL-519. The structures show altered interactions in the active site, flap-core interface, hydrophobic core, hinge region, and 80s loop compared to the corresponding wild-type protease structures. The ligand-free crystal structure exhibits a highly curled flap conformation which may amplify drug resistance. Molecular dynamics simulations performed for 1 μs on ligand-free dimers showed extremely large fluctuations in the flaps for PR10x compared to equivalent simulations on PR with a single L76V mutation or wild-type protease. This analysis offers insight about the synergistic effects of mutations in highly resistant variants.
PubMed: 36108568
DOI: 10.1016/j.jmgm.2022.108315
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.25 Å)
構造検証レポート
Validation report summary of 8dch
検証レポート(詳細版)ダウンロードをダウンロード

251801

件を2026-04-08に公開中

PDB statisticsPDBj update infoContact PDBjnumon